These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25662721)

  • 1. [Dysferlinopathy masquerading as a refractory polymyositis].
    Loureiro Amigo J; Gallardo E; Gallano P; Grau-Junyent JM
    Med Clin (Barc); 2015 Nov; 145(9):414-5. PubMed ID: 25662721
    [No Abstract]   [Full Text] [Related]  

  • 2. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
    Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
    Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ["Therapy-resistant polymyositis" - is the diagnosis correct?].
    Ceccon G; Lehmann HC; Neuen-Jacob E; Meng G; Fink GR; Wunderlich G
    Z Rheumatol; 2017 Sep; 76(7):640-643. PubMed ID: 28523511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysferlin deficiency treated like refractory polymyositis.
    Vinit J; Samson M; Gaultier JB; Laquerriere A; Ollagnon E; Petiot P; Marie I; Levesque H; Rousset H
    Clin Rheumatol; 2010 Jan; 29(1):103-6. PubMed ID: 19730931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bent spine syndrome: a phenotype of dysferlinopathy or a symptomatic DYSF gene mutation carrier.
    Gáti I; Danielsson O; Gunnarsson C; Vrethem M; Häggqvist B; Fredriksson BA; Landtblom AM
    Eur Neurol; 2012; 67(5):300-2. PubMed ID: 22517428
    [No Abstract]   [Full Text] [Related]  

  • 6. Late-onset dysferlinopathy presented as "liver enzyme" abnormalities: a technical note.
    Li F; Yin G; Xie Q; Shi G
    J Clin Rheumatol; 2014 Aug; 20(5):275-7. PubMed ID: 25036559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aspects on patients affected by dysferlin deficient muscular dystrophy.
    Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
    J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myositis or dystrophy? Traps and pitfalls.
    Benveniste O; Romero NB
    Presse Med; 2011 Apr; 40(4 Pt 2):e249-55. PubMed ID: 21377315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dysferlinopathy misdiagnosed with juvenile polymyositis in the pre-symptomatic stage of hyperCKemia: a case report and literature review.
    Contreras-Cubas C; Barajas-Olmos F; Frayre-Martínez MI; Siordia-Reyes G; Guízar-Sánchez CC; García-Ortiz H; Orozco L; Baca V
    BMC Med Genomics; 2022 Jun; 15(1):139. PubMed ID: 35725460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis by protein analysis of dysferlinopathy in two patients mistaken as polymyositis.
    Angelini C; Grisold W; Nigro V
    Acta Myol; 2011 Dec; 30(3):185-7. PubMed ID: 22616201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysferlinopathy in Chile: evidence of two novel mutations in the first reported cases.
    Bevilacqua JA; Krahn M; Pedraza L; Gejman R; Gonzalez S; Lévy N
    Genet Test Mol Biomarkers; 2009 Feb; 13(1):105-8. PubMed ID: 19309282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lariat branch point mutation in the dysferlin gene with mild limb-girdle muscular dystrophy.
    Sinnreich M; Therrien C; Karpati G
    Neurology; 2006 Apr; 66(7):1114-6. PubMed ID: 16606933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The limb-girdle muscular dystrophies.
    Wicklund MP; Kissel JT
    Neurol Clin; 2014 Aug; 32(3):729-49, ix. PubMed ID: 25037088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An autopsy case of a dysferlinopathy patient with cardiac involvement.
    Suzuki N; Takahashi T; Suzuki Y; Narikawa K; Kudo S; Suzuki H; Tateyama M; Aoki M
    Muscle Nerve; 2012 Feb; 45(2):298-9. PubMed ID: 22246893
    [No Abstract]   [Full Text] [Related]  

  • 15. 4th Annual Dysferlin Conference 11-14 September 2010, Washington, USA.
    Albrecht DE; Garg N; Rufibach LE; Williams BA; Monnier N; Hwang E; Mittal P
    Neuromuscul Disord; 2011 Apr; 21(4):304-10. PubMed ID: 21339068
    [No Abstract]   [Full Text] [Related]  

  • 16. A unique case of limb-girdle muscular dystrophy type 2A carrying novel compound heterozygous mutations in the human CAPN3 gene.
    Matsubara E; Tsuchiya A; Minami N; Nishino I; Pappolla MA; Shoji M; Abe K
    Eur J Neurol; 2007 Jul; 14(7):819-22. PubMed ID: 17594342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dysferlinopathy in Iran: Clinical and genetic report.
    Fatehi F; Nafissi S; Urtizberea JA; Blanck-Labelle V; Lévy N; Krahn M; Dbouk MB; Attarian S
    J Neurol Sci; 2015 Dec; 359(1-2):256-9. PubMed ID: 26671124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Autosomal recessive limb-girdle muscular dystrophy].
    Hernández-Caballero ME; Miranda-Duarte A; Escobar-Cedillo RE; Villegas-Castrejon H
    Rev Neurol; 2010 Oct; 51(8):489-96. PubMed ID: 20925031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limb-girdle muscular dystrophy type 2B misdiagnosed as polymyositis at the early stage: Case report and literature review.
    Xu C; Chen J; Zhang Y; Li J
    Medicine (Baltimore); 2018 May; 97(21):e10539. PubMed ID: 29794729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
    Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
    Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.